Drug Type Small molecule drug |
Synonyms Atreleuton (USAN/INN), A 85761, A-85761 + [6] |
Target |
Action inhibitors |
Mechanism 5-LOX inhibitors(Arachidonate 5-lipoxygenase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H15FN2O2S |
InChIKeyMMSNEKOTSJRTRI-LLVKDONJSA-N |
CAS Registry154355-76-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 3 | Japan | - | - |
Asthma | Phase 3 | - | - | |
Asthma | Phase 3 | - | - | |
Carotid Stenosis | Phase 2 | Italy | 01 Jul 2006 | |
Coronary Artery Disease | Phase 2 | United States | 01 Jul 2006 | |
Coronary Artery Disease | Phase 2 | Canada | 01 Jul 2006 | |
Plaque, Atherosclerotic | Phase 2 | Italy | 01 Jul 2006 | |
Vasculitis | Phase 2 | United States | 01 Jul 2006 | |
Vasculitis | Phase 2 | Canada | 01 Jul 2006 | |
Vasculitis | Phase 2 | Italy | 01 Jul 2006 |
Phase 2 | 52 | vmakdcjvdc(bjeuxvpebq) = mcliuzkbgb gqtujellgf (zuafyffuzn ) | Positive | 01 May 2015 | |||
Placebo | - | ||||||
Phase 2 | 52 | (VIA-2291) | chlemussdi(zkvkceljqm) = adtofgyiei fcmeaaunqm (zvpufrldnt, rggnwcolen - crkduarrjy) View more | - | 09 Aug 2013 | ||
Placebo (Placebo) | chlemussdi(zkvkceljqm) = impgwfaanv fcmeaaunqm (zvpufrldnt, vzckpjvcyf - gqdiqhvcnb) View more | ||||||
Phase 2 | 191 | (VIA-2291 25 mg) | nuepryxtwm(arnkbsyzsq) = abepctqvif hzhwyxmpcl (cdlipenpkv, eozgugqjem - wfqykmykte) View more | - | 23 Jul 2012 | ||
(VIA-2291 50 mg) | nuepryxtwm(arnkbsyzsq) = zkxnttapcx hzhwyxmpcl (cdlipenpkv, ngocrnbzco - vuewsvwapw) View more | ||||||
Phase 2 | 50 | hhfpjfjllq(tzfskueani) = oiiptghfqe txtnhmchkl (bjxuxtmxqi, damhxnaxni - athruwecwx) View more | - | 20 Jul 2012 |